Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Lifetime Data Analysis
|
July 25, 2020
Extensions of the absolute standardized hazard ratio and connections with measures of explained variation and variable importance
Michael R Crager
Genetic Epidemiology
|
July 28, 2012
Prospective calculation of identification power for individual genes in analyses controlling the false discovery rate
Michael R Crager
Statistics in Medicine
|
December 5, 2009
Gene identification using true discovery rate degree of association sets and estimates corrected for regression to the mean
Michael R Crager
Journal of Applied Statistics
|
December 15, 2015
Patient-specific meta-analysis for risk assessment using multivariate proportional hazards regression
Michael R Crager, Gong Tang
Journal of Biopharmaceutical Statistics
|
June 11, 2014
Separate class true discovery rate degree of association sets for biomarker identification
Michael R Crager, Murat Ahmed
Journal of the American College of Cardiology
|
March 14, 2007
Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE)
Michael J Koren, Michael R Crager, Michael Sweeney
Contemporary Clinical Trials
|
August 19, 2017
Adjusting for covariates in evaluating markers for selecting treatment, with application to guiding chemotherapy for treating estrogen-receptor-positive, node-positive breast cancer
Holly Janes, Marshall D Brown, Michael R Crager, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2020
Development and Validation of a Tool Integrating the 21-Gene Recurrence Score and Clinical-Pathological Features to Individualize Prognosis and Prediction of Chemotherapy Benefit in Early Breast Cancer
Joseph A Sparano, Michael R Crager, Gong Tang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2021
Reply to K. Ando et al
Joseph A Sparano, Michael R Crager, Gong Tang, et al.
JCO Precision Oncology
|
May 26, 2021
GPS Assay Association With Long-Term Cancer Outcomes: Twenty-Year Risk of Distant Metastasis and Prostate Cancer-Specific Mortality
Michael A Brooks, Lewis Thomas, Cristina Magi-Galluzzi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Lifetime Data Analysis
|
July 25, 2020
Extensions of the absolute standardized hazard ratio and connections with measures of explained variation and variable importance
Michael R Crager
Genetic Epidemiology
|
July 28, 2012
Prospective calculation of identification power for individual genes in analyses controlling the false discovery rate
Michael R Crager
Statistics in Medicine
|
December 5, 2009
Gene identification using true discovery rate degree of association sets and estimates corrected for regression to the mean
Michael R Crager
Journal of Applied Statistics
|
December 15, 2015
Patient-specific meta-analysis for risk assessment using multivariate proportional hazards regression
Michael R Crager, Gong Tang
Journal of Biopharmaceutical Statistics
|
June 11, 2014
Separate class true discovery rate degree of association sets for biomarker identification
Michael R Crager, Murat Ahmed
Journal of the American College of Cardiology
|
March 14, 2007
Long-term safety of a novel antianginal agent in patients with severe chronic stable angina: the Ranolazine Open Label Experience (ROLE)
Michael J Koren, Michael R Crager, Michael Sweeney
Contemporary Clinical Trials
|
August 19, 2017
Adjusting for covariates in evaluating markers for selecting treatment, with application to guiding chemotherapy for treating estrogen-receptor-positive, node-positive breast cancer
Holly Janes, Marshall D Brown, Michael R Crager, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2020
Development and Validation of a Tool Integrating the 21-Gene Recurrence Score and Clinical-Pathological Features to Individualize Prognosis and Prediction of Chemotherapy Benefit in Early Breast Cancer
Joseph A Sparano, Michael R Crager, Gong Tang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2021
Reply to K. Ando et al
Joseph A Sparano, Michael R Crager, Gong Tang, et al.
JCO Precision Oncology
|
May 26, 2021
GPS Assay Association With Long-Term Cancer Outcomes: Twenty-Year Risk of Distant Metastasis and Prostate Cancer-Specific Mortality
Michael A Brooks, Lewis Thomas, Cristina Magi-Galluzzi, et al.
Page
of 2